Clinical Trials
6 trialsNCT00059267 2024-11-15
Prevention of Recurrent Hepatitis B After Liver Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed
NCT03144804 2024-06-06
A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer
Massachusetts General Hospital
Phase 2 Completed
NCT03528941 2022-05-12
LLC1618
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT01580202 2017-06-29
Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine
Seoul National University Hospital
Phase 3 Completed
NCT00041327 2016-02-03
Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma
AIDS Malignancy Consortium
Phase 2 Completed
NCT00516945 2013-09-05
A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers
Hospital Authority, Hong Kong
Phase NA Completed